Quess Corp, India’s leading business services provider, announced the launch of its new healthcare vertical to address the shortage of healthcare professionals.
The vertical aims to provide trained healthcare manpower, home care solutions, and end-to-end hospital management services by identifying, training & upskilling healthcare professionals through a network of accredited medical training institutes, enabling quick & on-demand deployment.
Quess Corp has signed an MoU with the Association of Healthcare Providers (India) (AHPI), a not-for-profit representative body of healthcare providers, to evangelize formalization of training and staffing services for healthcare professionals and create a talent marketplace for private and public healthcare institutions.
The collaboration aspires to create a pipeline of trained paramedical and healthcare service professionals through a proposed hire-train-deploy model, besides building a digital pool of highly skilled, experienced, ready-to-hire doctors across India.
In addition to creating an organized demand and supply support service for healthcare manpower such as nurses, paramedics, doctors, phlebotomists, and lab technicians, the collaboration will also enable corporates to set up safer workspaces with adequate medical facilities, and to train candidates with endorsements from reputed domestic and international accreditations. Through this alliance, Quess Corp and AHPI plan to jointly work towards industry advocacy in critical areas of staffing and healthcare manpower management.
Dr Naresh Shetty, president, Quess Healthcare said, “In India, the healthcare segment faces dismaying challenges with an acute shortage of skilled manpower to the tune of six million paramedics today. We hope to bridge this gap and indisputably impact skill development and knowledge enhancement of the healthcare sector, which is the absolute need of the hour. Through tech-enabled skilling and access to a talent pool of trained professionals, we want to empower healthcare providers to cater to a wide public reach while providing access to quality healthcare for all.”
Dr Giridhar Gyani, director general, AHPI said “Improving the Indian healthcare system by expanding basic healthcare access to the larger community has been our long-standing commitment at AHPI. We are pleased to partner with Quess Corporation, the leading manpower service company, and believe that together, we can successfully redesign and advocate for the medical ecosystem with trained and qualified workforce.”
In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.
The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.
In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?
High duties on imports from Canada, Mexico and China raise problems for international supply chains.
Advanced Drug Delivery Systems Market, valued at USD 234.84 billion in 2023, is on a trajectory of significant growth, projected to reach USD 352.01 billion by 2032
The U.S. Food and Drug Administration on January 15, 2025, announced its decision to ban Red Dye No. 3 also referred to as Erythrosine.
Targeted drug delivery revolutionises treatment by focusing medications on specific tissues, reducing the impact on healthy cells. Scientists enhance this precision with carriers like microspheres and nanoparticles, controlling release and absorption. Microspheres, made from biodegradable proteins or polymers, sustain drug release, making them ideal for targeted therapies, especially in oncology. Beyond drug delivery, microspheres open new possibilities across industries—from next-gen coatings to thermal insulation. With tailored sizes, shapes, and materials, they drive advancements in pharmaceuticals, advanced materials, and more.
The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos. The FDA noted that this move aims to protect consumers from potential harm posed by asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.
As one of the most significant holidays in China, Chinese New Year (CNY) profoundly impacts global shipping, logistics, and supply chains. Scheduled to begin on January 29, 2025, this festive period lasts up to two weeks, with many factories, ports, and businesses shutting down or operating with limited staff. Understanding the implications of CNY on your supply chain is critical to avoid disruptions and ensure seamless operations.